Source link : https://www.newshealth.biz/health-news/stop-ripping-us-off-senate-goes-after-ozempic-maker-over-pricing/
Sen. Bernie Sanders (I-Vt.) on Tuesday challenged Novo Nordisk’s CEO to lower the cost of semaglutide (Ozempic, Wegovy) during a Senate Health, Education, Labor and Pensions (HELP) Committee hearing. Sanders, the chair of the committee, noted that in the U.S. — even after factoring in rebates that pharmacy benefit managers (PBMs) receive — the net […]
Author : News Health
Publish date : 2024-09-24 21:46:54
Copyright for syndicated content belongs to the linked Source.
inHealth